Intensive Statin Therapy and Coronary High-Intensity Plaques
The present study demonstrates that intensive statin therapy reduces HIP-PMR identified by noncontrast T1WI, which may represent a useful method for quantitatively monitoring changes in plaque vulnerability.
Conclusions
The present study demonstrates that intensive statin therapy reduces HIP-PMR identified by noncontrast T1WI, which may represent a useful method for quantitatively monitoring changes in plaque vulnerability.
SHARE
